Jacques Volckmann News Today

Sanofi has chosen drug discovery start-up Aqemia to boost the discovery of small molecule drug candidates, using a generative AI platform.

Following its acquisition of the former Sanofi site in Strasbourg, French CRO NovAliX, specialising in drug research and development, has announced plans to develop the site as a therapeutic innovation campus, including a centre for cryo-electron microscopy. Click to read more...

EU research chief Jean-Eric Paquet confirmed the European Commission is preparing to tweak the next set of Horizon Europe work programmes which will outline the calls for 2023 and 2024, as he reacted to criticism from researchers on the first year of the programme.